Ligand Pharmaceuticals Ratios (2010-2025) | LGND

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
Gross Margin (Quarter)	82.50%	61.20%	80.83%	78.75%	87.13%	75.34%	76.10%	57.10%	91.55%	93.67%	89.40%	94.16%	90.70%	93.00%	95.27%	93.37%	89.30%	93.90%	96.71%	94.99%
EBT Margin (Quarter)	12.37%	42.23%	25.56%	31.70%	-25.04%	17.28%	20.86%	47.91%	126.28%	12.03%	-36.95%	60.84%	366.22%	-157.45%	-12.23%	-91.56%	-110.69%	23.56%	122.24%	95.16%
EBIT Margin (Quarter)	10.12%	58.00%	26.31%	66.82%	5.84%	17.28%	20.84%	-39.89%	32.30%	-7.52%	9.36%	-11.95%	9.65%	-45.99%	6.07%	-22.51%	-79.89%	17.73%	47.58%	23.20%
EBITDA Margin (Quarter)	10.12%	58.00%	26.31%	66.82%	5.84%	17.28%	20.84%	-39.89%	32.30%	-7.52%	9.36%	-11.95%	9.65%	-45.99%	6.07%	-22.51%	-79.89%	17.73%	47.58%	23.20%
Operating Margin (Quarter)	10.12%	58.00%	26.31%	66.82%	5.84%	17.28%	20.84%	-39.89%	32.30%	-7.52%	9.36%	-11.95%	9.65%	-45.99%	6.07%	-22.51%	-79.89%	17.73%	47.58%	23.20%
Net Margin (Quarter)	-10.00%	-7.25%	-11.08%	-3.94%	-6.73%	-26.92%	-15.60%	-5.86%	-3.79%							-72.62%	-93.64%	10.18%	101.57%	75.06%
FCF Margin (Quarter)	15.78%	29.70%	33.21%	34.46%	129.08%	10.55%	27.29%	101.90%	71.70%	6.83%	23.64%	30.16%	60.13%	31.08%	-73.26%	237.43%	-56.60%	32.72%	11.71%	76.20%
Efficiency
Inventory Average (Quarter)	31.71M	38.44M	36.47M	30.16M	26.47M	25.19M	23.55M	17.81M	13.65M	20.46M	26.15M	24.68M	22.65M	20.00M	17.71M	15.43M	14.36M	15.05M	13.69M	10.51M
Assets Average (Quarter)	1,328.70M	1,275.70M	1,264.97M	1,285.62M	1,201.39M	1,090.74M	1,063.45M	906.64M	786.87M	784.59M	763.67M	778.22M	850.54M	890.14M	910.64M	948.32M	923.60M	927.02M	1,212.69M	1,518.70M
Equity Average (Quarter)	727.68M	766.18M	799.29M	816.61M	807.18M	797.78M	809.33M	706.89M	621.90M	655.60M	666.39M	684.40M	753.72M	790.86M	808.19M	835.81M	813.02M	811.45M	888.74M	983.69M
Invested Capital (Quarter)	745.84M	786.52M	812.07M	821.26M	793.19M	917.34M	892.90M	597.53M	723.11M	664.89M	667.90M	700.94M	806.52M	775.20M	841.18M	830.51M	795.59M	827.31M	950.17M	1,017.21M
Asset Utilization Ratio (Quarter)	0.15	0.19	0.20	0.19	0.19	0.19	0.19	0.22	0.26	0.23	0.20	0.17	0.14	0.15	0.17	0.18	0.20	0.20	0.21	0.18
Leverage & Solvency
Interest Coverage Ratio (Quarter)	0.81	9.37	3.54	8.44	2.70	19.78	37.17	-83.75	59.19	-6.98	0.00M	-25.63	21.19	-15.06	4.24	-10.91	-41.77	7.32	60.36	7.76
Debt to Equity (Quarter)						0.14	0.09	0.13	0.12										0.47	0.44
Debt Ratio (Quarter)						0.11	0.07	0.10	0.09										0.30	0.29
Equity Ratio (Quarter)	0.58	0.63	0.64	0.63	0.72	0.75	0.78	0.78	0.80	0.88	0.87	0.89	0.88	0.89	0.88	0.88	0.88	0.87	0.64	0.65
Times Interest Earned (Quarter)	0.81	9.37	3.54	8.44	2.70	19.78	37.17	-83.75	59.19	-6.98	0.00M	-25.63	21.19	-15.06	4.24	-10.91	-41.77	7.32	60.36	7.76
Valuation
Enterprise Value (Quarter)	-339.21M	-301.83M	-323.21M	-341.11M	-204.00M	-147.94M	-121.41M	-211.87M	-282.67M	-219.04M	-190.50M	-170.31M	-310.59M	-38.28M	-74.75M	-256.17M	-208.90M	-245.02M	-664.52M	-733.52M
Return Ratios
Return on Sales (Quarter)	-0.10%	-0.07%	-0.11%	-0.04%	-0.07%	-0.27%	-0.16%	-0.06%	-0.04%	-0.08%	-0.03%	-0.01%				-0.73%	-0.94%	0.10%	1.02%	0.75%
Return on Capital Employed (Quarter)	0.03%	0.06%	0.07%	0.08%	0.09%	0.07%	0.07%	0.00%	0.02%	0.01%	-0.01%	0.02%	0.00%	-0.02%	-0.02%	-0.02%	-0.07%	-0.04%	0.01%	0.03%
Return on Invested Capital (Quarter)	0.07%	0.14%	0.13%	0.13%	0.10%	0.06%	0.05%	0.00%	0.01%	0.00%	0.00%	0.01%	0.00%	-0.02%	-0.02%	0.04%	-0.06%	-0.04%	0.02%	0.03%
Return on Assets (Quarter)	0.02%	0.00%	0.00%	-0.01%	-0.01%	-0.02%	-0.03%	-0.03%	-0.03%	-0.02%	-0.01%	0.00%				-0.03%	-0.08%	-0.07%	0.04%	0.08%
Return on Equity (Quarter)	0.04%	0.00%	0.00%	-0.02%	-0.02%	-0.03%	-0.03%	-0.04%	-0.04%	-0.02%	-0.01%	0.00%				-0.04%	-0.09%	-0.08%	0.05%	0.13%

Research Tools

Ligand Pharmaceuticals Ratios (2010-2025) | LGND

Create an account

Sign In

Reset Password